Brief: C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion For Ibox Scoring System
21/12/2022 21:07
Dec 21 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* C-PATH'S TRANSPLANT THERAPEUTICS CONSORTIUM RECEIVES EMA
QUALIFICATION OPINION FOR IBOX SCORING SYSTEM
Source text for Eikon: ID:nGNXp4YC7
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial